Schedule 13G ownership disclosure
Bright Minds Biosciences Inc
Common Shares · CUSIP: 10919W405
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 206,427.00 · Class: 2.9%
- Peter Kolchinsky
Shares: 206,427.00 · Class: 2.9%
- Rajeev Shah
Shares: 206,427.00 · Class: 2.9%
- RA Capital Healthcare Fund, L.P.
Shares: 206,427.00 · Class: 2.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-013183
- Form type
- SCHEDULE 13G/A
- Filer
- BRIGHT MINDS BIOSCIENCES INC.
- CIK
- CIK 1827401
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership